Our animation explores the unique challenges a "no-deal" Brexit poses for the drug development and advanced therapy sectors.

We sit down with Nigel Theobald, Chief Executive, N4 Pharma. He tells us the story of his career and offers some advice for budding entrepreneurs.

Scouting for new leadership, prices hikes and successful acquisitions. What’s new for pharma in business?

Sam Herbert walks us through the past 50 years of pharma logistics.

Gene finds that the pressures of viral vector manufacturing are almost too much.

Fail to Prepare? Prepare to Fail…

Samsung Biologics give their opinion on working with the M Lab™ Collaboration Centers.

When EMD Serono wanted to increase drug production, they found that their manufacturing process did not have the required capacity.

Viral contamination can shut down a plant for months – affecting manufacturing, causing business disruption and threatening supply and patient safety.

Welcome to the M Lab™ Collaboration Centers – where customers can use non-GMP lab spaces to operate equipment, evaluate processes and receive...